← k3vl4r
Log inGet started →

JAZZ (Jazz Pharmaceuticals) Price Forecast

AI-generated price forecast for Jazz Pharmaceuticals (JAZZ) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of November 2026: K3vl4r's calibrated AI forecast currently reads JAZZ as 1/1 bullish across its horizons (1 of 1 timeframes pointing up), with a last price of 240.71. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP🔬 Deep research

Last price

240.71

AI outlook

1/1 bullish

Timeframes up

1 / 1

Share𝕏PostTelegram

JAZZ forecast by horizon

HorizonDirectionCalibrated move (end of horizon)
1-hour——
4-hour——
Daily~4 weeks out▲ Up+24.32%
WeeklyNot enough track record yet—

Calibrated: each horizon's forecast is weighted by how often the model has called JAZZ's direction correctly over the last 30 days, and reversed where it has been wrong more often than right. A horizon votes only once it has enough resolved forecasts.

Latest JAZZ news

From the market-news feed the forecasts are read against.

  • Jazz Pharmaceuticals plc (JAZZ) Presents at Jefferies Global Healthcare Conference 2026 Transcript · SeekingAlpha · Nov 17
  • Morgan Stanley Maintains Overweight on Jazz Pharmaceuticals, Raises Price Target to $324 · Benzinga · Nov 13
  • Piper Sandler Maintains Overweight on Jazz Pharmaceuticals, Raises Price Target to $330 · Benzinga · Nov 12
  • At Jazz Pharmaceuticals, Bruce C Cozadd Chooses To Exercise Options, Resulting In $9.46M · Benzinga · Nov 11
  • S&P 500 Just Wiped Out $3 Trillion: Why This 0.35-Beta Stock is a Safe Haven · Yahoo · Nov 9

🔒

See the full JAZZ forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

JAZZ forecast — frequently asked

Will JAZZ go up?

K3vl4r's calibrated AI forecast currently reads JAZZ as 1/1 bullish — 1 of 1 forecast horizons point up, so the overall read is leaning to the upside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the JAZZ price prediction for 2026?

K3vl4r's model projects JAZZ toward $299.26 over the next ~4 weeks, a +24.3% move from $240.71. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Biotech & Pharma forecasts — browse the full sector.

More AI forecasts

EDITNBIXVIRAGIOAMGNCRBUDNARXRXTMDXIRWDVRTXBNTXIOVAPRTA

Will JAZZ reach…?

Will JAZZ reach $500.00?Will JAZZ reach $1,000?

Or see the full JAZZ price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare JAZZ

JAZZ vs EDITJAZZ vs NBIXJAZZ vs VIRJAZZ vs AGIOJAZZ vs AMGNJAZZ vs CRBU

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rResearch libraryTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.